DE2261568A1 - 2-nitroindan-1,3-dion-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate - Google Patents
2-nitroindan-1,3-dion-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparateInfo
- Publication number
- DE2261568A1 DE2261568A1 DE19722261568 DE2261568A DE2261568A1 DE 2261568 A1 DE2261568 A1 DE 2261568A1 DE 19722261568 DE19722261568 DE 19722261568 DE 2261568 A DE2261568 A DE 2261568A DE 2261568 A1 DE2261568 A1 DE 2261568A1
- Authority
- DE
- Germany
- Prior art keywords
- dione
- nitroindan
- medicinal preparations
- compounds
- nitroindane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims description 59
- 238000002360 preparation method Methods 0.000 title claims description 17
- 238000000034 method Methods 0.000 title claims description 15
- CJGMVHVKJXBIDT-UHFFFAOYSA-N 2-nitroindene-1,3-dione Chemical class C1=CC=C2C(=O)C([N+](=O)[O-])C(=O)C2=C1 CJGMVHVKJXBIDT-UHFFFAOYSA-N 0.000 title claims description 11
- 238000004519 manufacturing process Methods 0.000 title description 2
- -1 chloro-2-nitroindan-1,3-d ion Chemical class 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 12
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 11
- 238000006396 nitration reaction Methods 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 6
- UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-indandione Chemical compound C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- FTGCGMAEGVRUQD-UHFFFAOYSA-N 6-ethyl-4-methoxy-2-nitroindene-1,3-dione Chemical compound COC1=CC(CC)=CC2=C1C(=O)C([N+]([O-])=O)C2=O FTGCGMAEGVRUQD-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 claims description 2
- ZBILDHBSHNRXLN-UHFFFAOYSA-N 4,5-dimethoxy-2-nitroindene-1,3-dione Chemical compound COC1=CC=C2C(=O)C([N+]([O-])=O)C(=O)C2=C1OC ZBILDHBSHNRXLN-UHFFFAOYSA-N 0.000 claims description 2
- BVIWPSQRCCWTLC-UHFFFAOYSA-N 5-bromo-2-nitroindene-1,3-dione Chemical compound C1=C(Br)C=C2C(=O)C([N+](=O)[O-])C(=O)C2=C1 BVIWPSQRCCWTLC-UHFFFAOYSA-N 0.000 claims description 2
- QSXFVDDYPAUVEQ-UHFFFAOYSA-N 5-chloro-2-nitroindene-1,3-dione Chemical compound C1=C(Cl)C=C2C(=O)C([N+](=O)[O-])C(=O)C2=C1 QSXFVDDYPAUVEQ-UHFFFAOYSA-N 0.000 claims description 2
- RWXCIPGRBNIYJI-UHFFFAOYSA-N 5-iodo-2-nitroindene-1,3-dione Chemical compound C1=C(I)C=C2C(=O)C([N+](=O)[O-])C(=O)C2=C1 RWXCIPGRBNIYJI-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000002837 carbocyclic group Chemical group 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 238000005121 nitriding Methods 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims 3
- ALOOMSZBHTWGKM-UHFFFAOYSA-N 4-butoxy-2-nitroindene-1,3-dione Chemical compound CCCCOC1=CC=CC2=C1C(=O)C([N+]([O-])=O)C2=O ALOOMSZBHTWGKM-UHFFFAOYSA-N 0.000 claims 2
- OCJFPAUIRWLATM-UHFFFAOYSA-N 5-methyl-2-nitroindene-1,3-dione Chemical compound CC1=CC=C2C(=O)C([N+]([O-])=O)C(=O)C2=C1 OCJFPAUIRWLATM-UHFFFAOYSA-N 0.000 claims 2
- 229940124630 bronchodilator Drugs 0.000 claims 2
- 230000000144 pharmacologic effect Effects 0.000 claims 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 claims 1
- SURCGQGDUADKBL-UHFFFAOYSA-N 2-(2-hydroxyethylamino)-5-nitrobenzo[de]isoquinoline-1,3-dione Chemical compound [O-][N+](=O)C1=CC(C(N(NCCO)C2=O)=O)=C3C2=CC=CC3=C1 SURCGQGDUADKBL-UHFFFAOYSA-N 0.000 claims 1
- KMQFWCXRCDQFFQ-UHFFFAOYSA-N 5,6-dimethyl-2-nitroindene-1,3-dione Chemical compound C1=C(C)C(C)=CC2=C1C(=O)C([N+]([O-])=O)C2=O KMQFWCXRCDQFFQ-UHFFFAOYSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 1
- JNJJJTVCSKJOTH-UHFFFAOYSA-N [O-][N+](C(CC1=CC=CC=C11)C1F)=O Chemical compound [O-][N+](C(CC1=CC=CC=C11)C1F)=O JNJJJTVCSKJOTH-UHFFFAOYSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000012876 carrier material Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229960001317 isoprenaline Drugs 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 62
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 60
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 60
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 41
- 238000001953 recrystallisation Methods 0.000 description 41
- 239000000243 solution Substances 0.000 description 29
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000203 mixture Substances 0.000 description 19
- 238000002844 melting Methods 0.000 description 18
- 230000008018 melting Effects 0.000 description 18
- 238000009835 boiling Methods 0.000 description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 11
- 238000001816 cooling Methods 0.000 description 11
- 239000002480 mineral oil Substances 0.000 description 11
- 235000010446 mineral oil Nutrition 0.000 description 11
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 10
- 239000012312 sodium hydride Substances 0.000 description 10
- 229910000104 sodium hydride Inorganic materials 0.000 description 10
- 159000000000 sodium salts Chemical class 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 239000003208 petroleum Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 238000003512 Claisen condensation reaction Methods 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 238000006114 decarboxylation reaction Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 238000002255 vaccination Methods 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 208000024780 Urticaria Diseases 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 3
- 108010058846 Ovalbumin Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- SDJHPPZKZZWAKF-UHFFFAOYSA-N 2,3-dimethylbuta-1,3-diene Chemical compound CC(=C)C(C)=C SDJHPPZKZZWAKF-UHFFFAOYSA-N 0.000 description 2
- XNMQEEKYCVKGBD-UHFFFAOYSA-N 2-butyne Chemical group CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 230000000802 nitrating effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- JKUYRAMKJLMYLO-UHFFFAOYSA-N tert-butyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OC(C)(C)C JKUYRAMKJLMYLO-UHFFFAOYSA-N 0.000 description 2
- KPWGMCBYMVBYKG-UHFFFAOYSA-N 2-nitro-4-phenylindene-1,3-dione Chemical compound C=12C(=O)C([N+](=O)[O-])C(=O)C2=CC=CC=1C1=CC=CC=C1 KPWGMCBYMVBYKG-UHFFFAOYSA-N 0.000 description 1
- PVOTZRBMRZWVED-UHFFFAOYSA-N 2-nitro-4-propan-2-yloxyindene-1,3-dione Chemical compound CC(C)OC1=CC=CC2=C1C(=O)C([N+]([O-])=O)C2=O PVOTZRBMRZWVED-UHFFFAOYSA-N 0.000 description 1
- KVMSIBDBCOEQSS-UHFFFAOYSA-N 2-nitro-4-propoxyindene-1,3-dione Chemical compound CCCOC1=CC=CC2=C1C(=O)C([N+]([O-])=O)C2=O KVMSIBDBCOEQSS-UHFFFAOYSA-N 0.000 description 1
- MEYHXRCEVIUWJB-UHFFFAOYSA-N 2-nitrocyclopenta[a]naphthalene-1,3-dione Chemical compound C1=CC=CC2=C(C(C([N+](=O)[O-])C3=O)=O)C3=CC=C21 MEYHXRCEVIUWJB-UHFFFAOYSA-N 0.000 description 1
- NMGBFVPQUCLJGM-UHFFFAOYSA-N 3-ethylphthalic acid Chemical compound CCC1=CC=CC(C(O)=O)=C1C(O)=O NMGBFVPQUCLJGM-UHFFFAOYSA-N 0.000 description 1
- FKJORNYLBXVNBF-UHFFFAOYSA-N 3-methoxy-5-methylphthalic acid Chemical compound COC1=CC(C)=CC(C(O)=O)=C1C(O)=O FKJORNYLBXVNBF-UHFFFAOYSA-N 0.000 description 1
- DULQZGQVLHMCAU-UHFFFAOYSA-N 3-methoxyphthalic acid Chemical compound COC1=CC=CC(C(O)=O)=C1C(O)=O DULQZGQVLHMCAU-UHFFFAOYSA-N 0.000 description 1
- WFFZGYRTVIPBFN-UHFFFAOYSA-N 3h-indene-1,2-dione Chemical compound C1=CC=C2C(=O)C(=O)CC2=C1 WFFZGYRTVIPBFN-UHFFFAOYSA-N 0.000 description 1
- CYUJGLFOZYZGCH-UHFFFAOYSA-N 4,6-dimethyl-2-nitroindene-1,3-dione Chemical compound CC1=CC(C)=CC2=C1C(=O)C([N+]([O-])=O)C2=O CYUJGLFOZYZGCH-UHFFFAOYSA-N 0.000 description 1
- KLUILWQGFBJFNI-UHFFFAOYSA-N 4,6-dimethylindene-1,3-dione Chemical compound CC1=CC(C)=CC2=C1C(=O)CC2=O KLUILWQGFBJFNI-UHFFFAOYSA-N 0.000 description 1
- WEPCDISQBQXOBE-UHFFFAOYSA-N 4,7-dimethyl-2-benzofuran-1,3-dione Chemical compound CC1=CC=C(C)C2=C1C(=O)OC2=O WEPCDISQBQXOBE-UHFFFAOYSA-N 0.000 description 1
- NFNVJUIXJQURPE-UHFFFAOYSA-N 4-(2-methylpropoxy)-2-nitroindene-1,3-dione Chemical compound CC(C)COC1=CC=CC2=C1C(=O)C([N+]([O-])=O)C2=O NFNVJUIXJQURPE-UHFFFAOYSA-N 0.000 description 1
- CLZNUZNABAVUBI-UHFFFAOYSA-N 4-(2-methylpropoxy)indene-1,3-dione Chemical compound CC(C)COC1=CC=CC2=C1C(=O)CC2=O CLZNUZNABAVUBI-UHFFFAOYSA-N 0.000 description 1
- SUQVGFUAHDXGSX-UHFFFAOYSA-N 4-bromo-2-nitroindene-1,3-dione Chemical compound C1=CC(Br)=C2C(=O)C([N+](=O)[O-])C(=O)C2=C1 SUQVGFUAHDXGSX-UHFFFAOYSA-N 0.000 description 1
- SQBHQKFWZYZVAT-UHFFFAOYSA-N 4-bromoindene-1,3-dione Chemical compound BrC1=CC=CC2=C1C(=O)CC2=O SQBHQKFWZYZVAT-UHFFFAOYSA-N 0.000 description 1
- LFHCXMQLAZEASX-UHFFFAOYSA-N 4-butoxyindene-1,3-dione Chemical compound CCCCOC1=CC=CC2=C1C(=O)CC2=O LFHCXMQLAZEASX-UHFFFAOYSA-N 0.000 description 1
- NASMMQBISWGBEJ-UHFFFAOYSA-N 4-chloro-2-nitroindene-1,3-dione Chemical compound C1=CC(Cl)=C2C(=O)C([N+](=O)[O-])C(=O)C2=C1 NASMMQBISWGBEJ-UHFFFAOYSA-N 0.000 description 1
- CTSZYBUVLHRTKF-UHFFFAOYSA-N 4-methoxy-6-methyl-2-nitroindene-1,3-dione Chemical compound COC1=CC(C)=CC2=C1C(=O)C([N+]([O-])=O)C2=O CTSZYBUVLHRTKF-UHFFFAOYSA-N 0.000 description 1
- ALGRPRMNTYPWDJ-UHFFFAOYSA-N 4-methoxy-7-methyl-2-benzofuran-1,3-dione Chemical compound COC1=CC=C(C)C2=C1C(=O)OC2=O ALGRPRMNTYPWDJ-UHFFFAOYSA-N 0.000 description 1
- MORUHGIHMXAGPF-UHFFFAOYSA-N 4-methoxy-7-methyl-2-nitroindene-1,3-dione Chemical compound COC1=CC=C(C)C2=C1C(=O)C([N+]([O-])=O)C2=O MORUHGIHMXAGPF-UHFFFAOYSA-N 0.000 description 1
- KIPJWBIFGVJGIU-UHFFFAOYSA-N 4-methyl-2-nitroindene-1,3-dione Chemical compound CC1=CC=CC2=C1C(=O)C([N+]([O-])=O)C2=O KIPJWBIFGVJGIU-UHFFFAOYSA-N 0.000 description 1
- OUSZUVCKXGFZHR-UHFFFAOYSA-N 4-methylindene-1,3-dione Chemical compound CC1=CC=CC2=C1C(=O)CC2=O OUSZUVCKXGFZHR-UHFFFAOYSA-N 0.000 description 1
- YYEWRNLQOAIQDL-UHFFFAOYSA-N 4-phenylphthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=CC=C1 YYEWRNLQOAIQDL-UHFFFAOYSA-N 0.000 description 1
- IVODYRJOJFDUPA-UHFFFAOYSA-N 4-propan-2-yloxyindene-1,3-dione Chemical compound CC(C)OC1=CC=CC2=C1C(=O)CC2=O IVODYRJOJFDUPA-UHFFFAOYSA-N 0.000 description 1
- BCKVHOUUJMYIAN-UHFFFAOYSA-N 5-bromo-2-benzofuran-1,3-dione Chemical compound BrC1=CC=C2C(=O)OC(=O)C2=C1 BCKVHOUUJMYIAN-UHFFFAOYSA-N 0.000 description 1
- XVMKZAAFVWXIII-UHFFFAOYSA-N 5-fluoro-2-benzofuran-1,3-dione Chemical compound FC1=CC=C2C(=O)OC(=O)C2=C1 XVMKZAAFVWXIII-UHFFFAOYSA-N 0.000 description 1
- GZQGKILKRFAGDF-UHFFFAOYSA-N 5-methoxy-2-nitroindene-1,3-dione Chemical compound COC1=CC=C2C(=O)C([N+]([O-])=O)C(=O)C2=C1 GZQGKILKRFAGDF-UHFFFAOYSA-N 0.000 description 1
- RMQQJCQNLSHFHS-UHFFFAOYSA-N 5-methoxy-6-methylindene-1,3-dione Chemical compound C1=C(C)C(OC)=CC2=C1C(=O)CC2=O RMQQJCQNLSHFHS-UHFFFAOYSA-N 0.000 description 1
- OOGJCWRSXJSCJR-UHFFFAOYSA-N 5-methylindene-1,3-dione Chemical compound CC1=CC=C2C(=O)CC(=O)C2=C1 OOGJCWRSXJSCJR-UHFFFAOYSA-N 0.000 description 1
- NNNOEYRPZFYOIS-UHFFFAOYSA-N 5-phenylindene-1,3-dione Chemical compound C=1C=C2C(=O)CC(=O)C2=CC=1C1=CC=CC=C1 NNNOEYRPZFYOIS-UHFFFAOYSA-N 0.000 description 1
- NUOSRFATOXIEJI-UHFFFAOYSA-N 6-ethyl-4-methoxyindene-1,3-dione Chemical compound COC1=CC(CC)=CC2=C1C(=O)CC2=O NUOSRFATOXIEJI-UHFFFAOYSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000551547 Dione <red algae> Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000012754 cardiac puncture Methods 0.000 description 1
- BPHHNXJPFPEJOF-UHFFFAOYSA-J chembl296966 Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)C1=CC(S([O-])(=O)=O)=C(N)C2=C(O)C(N=NC3=CC=C(C=C3OC)C=3C=C(C(=CC=3)N=NC=3C(=C4C(N)=C(C=C(C4=CC=3)S([O-])(=O)=O)S([O-])(=O)=O)O)OC)=CC=C21 BPHHNXJPFPEJOF-UHFFFAOYSA-J 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- LBJNMUFDOHXDFG-UHFFFAOYSA-N copper;hydrate Chemical compound O.[Cu].[Cu] LBJNMUFDOHXDFG-UHFFFAOYSA-N 0.000 description 1
- QMNXUENRZFQJOB-UHFFFAOYSA-N cyclopenta[a]naphthalene-1,3-dione Chemical compound C1=CC2=CC=CC=C2C2=C1C(=O)CC2=O QMNXUENRZFQJOB-UHFFFAOYSA-N 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- CSJDDDONKCSXPX-UHFFFAOYSA-N diethyl 3-methylbenzene-1,2-dicarboxylate Chemical compound CCOC(=O)C1=CC=CC(C)=C1C(=O)OCC CSJDDDONKCSXPX-UHFFFAOYSA-N 0.000 description 1
- VMODTUAZZAIDGU-UHFFFAOYSA-N diethyl 4-methylbenzene-1,2-dicarboxylate Chemical compound CCOC(=O)C1=CC=C(C)C=C1C(=O)OCC VMODTUAZZAIDGU-UHFFFAOYSA-N 0.000 description 1
- UHTTVNLQYKRJIP-UHFFFAOYSA-N dimethyl 2,3-dihydro-1h-indene-4,5-dicarboxylate Chemical compound COC(=O)C1=CC=C2CCCC2=C1C(=O)OC UHTTVNLQYKRJIP-UHFFFAOYSA-N 0.000 description 1
- CYHHFDSYILYGJK-UHFFFAOYSA-N dimethyl 3,5-dimethylbenzene-1,2-dicarboxylate Chemical compound COC(=O)C1=CC(C)=CC(C)=C1C(=O)OC CYHHFDSYILYGJK-UHFFFAOYSA-N 0.000 description 1
- SRVVCVXNCDLHFO-UHFFFAOYSA-N dimethyl 3-butoxybenzene-1,2-dicarboxylate Chemical compound CCCCOC1=CC=CC(C(=O)OC)=C1C(=O)OC SRVVCVXNCDLHFO-UHFFFAOYSA-N 0.000 description 1
- DKAXMMVRWZGLNQ-UHFFFAOYSA-N dimethyl 3-ethoxybenzene-1,2-dicarboxylate Chemical compound CCOC1=CC=CC(C(=O)OC)=C1C(=O)OC DKAXMMVRWZGLNQ-UHFFFAOYSA-N 0.000 description 1
- BHISBMLCPDHRHT-UHFFFAOYSA-N dimethyl 3-ethylbenzene-1,2-dicarboxylate Chemical compound CCC1=CC=CC(C(=O)OC)=C1C(=O)OC BHISBMLCPDHRHT-UHFFFAOYSA-N 0.000 description 1
- JKJKZHLNKRHCFA-UHFFFAOYSA-N dimethyl 3-propan-2-yloxybenzene-1,2-dicarboxylate Chemical compound COC(=O)C1=CC=CC(OC(C)C)=C1C(=O)OC JKJKZHLNKRHCFA-UHFFFAOYSA-N 0.000 description 1
- FQOJAKYIPJAQPS-UHFFFAOYSA-N dimethyl 3-propoxybenzene-1,2-dicarboxylate Chemical compound CCCOC1=CC=CC(C(=O)OC)=C1C(=O)OC FQOJAKYIPJAQPS-UHFFFAOYSA-N 0.000 description 1
- BMODQQWZCVNPKL-UHFFFAOYSA-N dimethyl 4,5-dimethylbenzene-1,2-dicarboxylate Chemical compound COC(=O)C1=CC(C)=C(C)C=C1C(=O)OC BMODQQWZCVNPKL-UHFFFAOYSA-N 0.000 description 1
- CVFAUXQYWPECKA-UHFFFAOYSA-N dimethyl 4,5-dimethylcyclohexa-1,4-diene-1,2-dicarboxylate Chemical compound COC(=O)C1=C(C(=O)OC)CC(C)=C(C)C1 CVFAUXQYWPECKA-UHFFFAOYSA-N 0.000 description 1
- PBHDDYJJBJNTLH-UHFFFAOYSA-N dimethyl 4-methoxy-5-methylbenzene-1,2-dicarboxylate Chemical compound COC(=O)C1=CC(C)=C(OC)C=C1C(=O)OC PBHDDYJJBJNTLH-UHFFFAOYSA-N 0.000 description 1
- MINFPQZYHRBMNP-UHFFFAOYSA-N dimethyl 4-phenylbenzene-1,2-dicarboxylate Chemical compound C1=C(C(=O)OC)C(C(=O)OC)=CC=C1C1=CC=CC=C1 MINFPQZYHRBMNP-UHFFFAOYSA-N 0.000 description 1
- JRCHRQNLEBCDGP-UHFFFAOYSA-N dimethyl 5,6,7,8-tetrahydronaphthalene-1,2-dicarboxylate Chemical compound C1CCCC2=C(C(=O)OC)C(C(=O)OC)=CC=C21 JRCHRQNLEBCDGP-UHFFFAOYSA-N 0.000 description 1
- VHILMKFSCRWWIJ-UHFFFAOYSA-N dimethyl acetylenedicarboxylate Chemical compound COC(=O)C#CC(=O)OC VHILMKFSCRWWIJ-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 239000003041 laboratory chemical Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- VOVZXURTCKPRDQ-CQSZACIVSA-N n-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide Chemical compound C1[C@H](O)CCN1C1=NC=C(C(=O)NC=2C=CC(OC(F)(F)Cl)=CC=2)C=C1C1=CC=NN1 VOVZXURTCKPRDQ-CQSZACIVSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 125000005920 sec-butoxy group Chemical group 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- AUHHYELHRWCWEZ-UHFFFAOYSA-N tetrachlorophthalic anhydride Chemical compound ClC1=C(Cl)C(Cl)=C2C(=O)OC(=O)C2=C1Cl AUHHYELHRWCWEZ-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds
- C07C62/38—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/48—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation involving decarboxylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/675—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1330072*[A GB1412291A (en) | 1972-01-25 | 1972-01-25 | 2-nitro-indan-1,3-diones methods for their preparation and anti-allergic compositions containing them |
| GB1330072 | 1972-03-22 | ||
| GB2870772 | 1972-06-20 | ||
| GB4802772 | 1972-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2261568A1 true DE2261568A1 (de) | 1973-08-02 |
Family
ID=27447285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19722261568 Pending DE2261568A1 (de) | 1972-01-25 | 1972-12-15 | 2-nitroindan-1,3-dion-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3936504A (enExample) |
| BE (1) | BE792867A (enExample) |
| CA (2) | CA1017757A (enExample) |
| CH (1) | CH592603A5 (enExample) |
| DE (1) | DE2261568A1 (enExample) |
| DK (2) | DK137379B (enExample) |
| FR (1) | FR2181661B1 (enExample) |
| GB (1) | GB1412291A (enExample) |
| NL (1) | NL7217175A (enExample) |
| NO (1) | NO135632C (enExample) |
| SE (2) | SE401821B (enExample) |
-
1972
- 1972-01-25 GB GB1330072*[A patent/GB1412291A/en not_active Expired
- 1972-12-14 SE SE7216376A patent/SE401821B/xx unknown
- 1972-12-15 DK DK629972AA patent/DK137379B/da unknown
- 1972-12-15 DE DE19722261568 patent/DE2261568A1/de active Pending
- 1972-12-15 BE BE792867D patent/BE792867A/xx unknown
- 1972-12-15 NO NO4655/72A patent/NO135632C/no unknown
- 1972-12-15 NL NL7217175A patent/NL7217175A/xx not_active Application Discontinuation
- 1972-12-15 CA CA159,009A patent/CA1017757A/en not_active Expired
- 1972-12-15 CH CH1833772A patent/CH592603A5/xx not_active IP Right Cessation
- 1972-12-21 US US05/317,296 patent/US3936504A/en not_active Expired - Lifetime
-
1973
- 1973-01-10 FR FR7300713A patent/FR2181661B1/fr not_active Expired
-
1976
- 1976-09-17 SE SE7610364A patent/SE7610364L/xx unknown
- 1976-12-09 CA CA267,480A patent/CA1021799A/en not_active Expired
-
1977
- 1977-12-15 DK DK560577A patent/DK560577A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1017757A (en) | 1977-09-20 |
| NO135632C (enExample) | 1977-05-04 |
| NL7217175A (enExample) | 1973-07-27 |
| CA1021799A (en) | 1977-11-29 |
| NO135632B (enExample) | 1977-01-24 |
| DK137379C (enExample) | 1978-08-07 |
| FR2181661A1 (enExample) | 1973-12-07 |
| US3936504A (en) | 1976-02-03 |
| BE792867A (fr) | 1973-06-15 |
| DK137379B (da) | 1978-02-27 |
| SE7610364L (sv) | 1976-09-17 |
| FR2181661B1 (enExample) | 1976-06-25 |
| GB1412291A (en) | 1975-11-05 |
| DK560577A (da) | 1977-12-15 |
| SE401821B (sv) | 1978-05-29 |
| CH592603A5 (enExample) | 1977-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2402398A1 (de) | Neue aromatische carbonsaeureamidderivate | |
| DE69107959T2 (de) | 3-Cycloalkylpropansäureamide, ihre Tautomere und Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen. | |
| DE2136950A1 (de) | Pyrazolo(3,4 d)pynmidinderivate und deren Salze, Herstellung solcher Substanzen und Arzneimittel mit einem Gehalt daran | |
| DE2418344A1 (de) | Derivate von 3-nitrocumarinen enthaltende arzneimittel, neue 3-nitrocumarine und verfahren zu ihrer herstellung | |
| DE2931418C2 (enExample) | ||
| EP0185909B1 (de) | 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2428486A1 (de) | Azapurinone | |
| DE2656468A1 (de) | N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung | |
| DE1695656C3 (enExample) | ||
| DE2119730B2 (de) | Verfahren zur herstellung von 1,2-benzisothiazolin-3-onen | |
| EP0072960B1 (de) | 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2253914C3 (de) | Chromon-3-acrylsaeuren, verfahren zu ihrer herstellung sowie diese verbindung enthaltende arzneimittel | |
| DE2448389A1 (de) | Derivate von 4-hydroxy-3-nitro-alpha- pyridonen enthaltende arzneimittel, neue 4-hydroxy-3-nitro-alpha-pyridone und verfahren zu ihrer herstellung | |
| DE2261568A1 (de) | 2-nitroindan-1,3-dion-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
| DE2424076A1 (de) | Derivate von 4-hydroxy-3-nitrocarbostyrilen enthaltende arzneimittel, neue 4-hydroxy-3-nitrocarbostyrile und verfahren zu ihrer herstellung | |
| DE2235572A1 (de) | Neue verbindungen | |
| DE2151487A1 (de) | Pharmazeutische Massen | |
| DE2922231C2 (enExample) | ||
| AT318598B (de) | Verfahren zur Herstellung von neuen 2-Nitroindan-1,3-dionderivaten | |
| DE1695092A1 (de) | Verfahren zur Herstellung von Sulfonamiden | |
| DE2649855C2 (de) | Substituierte 5-Acetyl-4-hydroxy-3-phenylamino-2H-pyran-2,6(3H)-dione, Verfahren zu deren Herstellung und deren Verwendung | |
| DE2752361A1 (de) | Neue indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| CH647235A5 (de) | 4-(2,2-dialkylindan-1-yliden)piperidin derivate, ihre herstellung und verwendung. | |
| DE2000339C3 (de) | Isochinolinderivate | |
| DE2050092C3 (de) | Chinazolondiurethane, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |